CaltechAUTHORS
  A Caltech Library Service

Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease

Fitzmaurice, Arthur G. and Rhodes, Shannon L. and Lulla, Aaron and Murphy, Niall P. and Lam, Hoa A. and O'Donnell, Kelley C. and Barnhill, Lisa and Casida, John E. and Cockburn, Myles and Sagasti, Alvaro and Stahl, Mark C. and Maidment, Nigel T. and Ritz, Beate and Bronstein, Jeff M. (2013) Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease. Proceedings of the National Academy of Sciences of the United States of America, 110 (2). pp. 636-641. ISSN 0027-8424. PMCID PMC3545765. https://resolver.caltech.edu/CaltechAUTHORS:20130301-155538652

[img]
Preview
PDF - Published Version
See Usage Policy.

1072Kb
[img]
Preview
PDF - Supplemental Material
See Usage Policy.

37Kb

Use this Persistent URL to link to this item: https://resolver.caltech.edu/CaltechAUTHORS:20130301-155538652

Abstract

Parkinson disease (PD) is a neurodegenerative disorder particularly characterized by the loss of dopaminergic neurons in the substantia nigra. Pesticide exposure has been associated with PD occurrence, and we previously reported that the fungicide benomyl interferes with several cellular processes potentially relevant to PD pathogenesis. Here we propose that benomyl, via its bioactivated thiocarbamate sulfoxide metabolite, inhibits aldehyde dehydrogenase (ALDH), leading to accumulation of the reactive dopamine metabolite 3,4-dihydroxyphenylacetaldehyde (DOPAL), preferential degeneration of dopaminergic neurons, and development of PD. This hypothesis is supported by multiple lines of evidence. (i) We previously showed in mice the metabolism of benomyl to S-methyl N-butylthiocarbamate sulfoxide, which inhibits ALDH at nanomolar levels. We report here that benomyl exposure in primary mesencephalic neurons (ii) inhibits ALDH and (iii) alters dopamine homeostasis. It induces selective dopaminergic neuronal damage (iv) in vitro in primary mesencephalic cultures and (v) in vivo in a zebrafish system. (vi) In vitro cell loss was attenuated by reducing DOPAL formation. (vii) In our epidemiology study, higher exposure to benomyl was associated with increased PD risk. This ALDH model for PD etiology may help explain the selective vulnerability of dopaminergic neurons in PD and provide a potential mechanism through which environmental toxicants contribute to PD pathogenesis.


Item Type:Article
Related URLs:
URLURL TypeDescription
http://dx.doi.org/10.1073/pnas.1220399110DOIArticle
http://www.ncbi.nlm.nih.gov/pmc/articles/pmc3545765/PatentArticle
Additional Information:© 2013 National Academy of Sciences. Contributed by John E. Casida, November 27, 2012; Sent for review October 19, 2012. Published online before print December 24, 2012. We thank Dr. Neil Harris for use of the Zeiss LSM 5 Pascal microscope. This work was funded in part by National Institute of Environmental Health Sciences Grants P01ES016732, R01ES010544, 5R21ES16446-2, and U54ES012078; National Institute of Neurological Disorders and Stroke Grant NS038367; the Veterans Affairs Healthcare System(Southwest Parkinson’s Disease Research, Education, and Clinical Center); the Michael J. Fox Foundation; the Levine Foundation; and the Parkinson Alliance. A.G.F. was supported in part by a National Defense Science and Engineering Graduate Fellowship and US Department of Health and Human Services Ruth L. Kirschstein Institutional National Research Service Award T32ES015457 in Molecular Toxicology (to the University of California, Los Angeles). Author contributions: A.G.F., S.L.R., J.E.C., B.R., and J.M.B. designed research; A.G.F., S.L.R., A.L., N.P.M., H.A.L., K.C.O., and M.C.S. performed research; J.E.C., M.C., and A.S. contributed new reagents/analytic tools; A.G.F., S.L.R., N.P.M., L.B., and N.T.M. analyzed data; and A.G.F., S.L.R., J.E.C., and J.M.B. wrote the paper. The authors declare no conflict of interest.
Funders:
Funding AgencyGrant Number
NIHP01ES016732
NIHR01ES010544
NIH5R21ES16446-2
NIHU54ES012078
NIHNS038367
Department of Veterans AffairsUNSPECIFIED
Parkinson AllianceUNSPECIFIED
National Defense Science and Engineering Graduate (NDSEG) FellowshipUNSPECIFIED
NIH Predoctoral FellowshipT32ES015457
Michael J. Fox FoundationUNSPECIFIED
Levine FoundationUNSPECIFIED
Issue or Number:2
PubMed Central ID:PMC3545765
Record Number:CaltechAUTHORS:20130301-155538652
Persistent URL:https://resolver.caltech.edu/CaltechAUTHORS:20130301-155538652
Official Citation: Arthur G. Fitzmaurice, Shannon L. Rhodes, Aaron Lulla, Niall P. Murphy, Hoa A. Lam, Kelley C. O’Donnell, Lisa Barnhill, John E. Casida, Myles Cockburn, Alvaro Sagasti, Mark C. Stahl, Nigel T. Maidment, Beate Ritz, and Jeff M. Bronstein Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease PNAS 2013 110 (2) 636-641; published ahead of print December 24, 2012, doi:10.1073/pnas.1220399110
Usage Policy:No commercial reproduction, distribution, display or performance rights in this work are provided.
ID Code:37260
Collection:CaltechAUTHORS
Deposited By: Aucoeur Ngo
Deposited On:04 Mar 2013 15:30
Last Modified:02 Jun 2020 20:14

Repository Staff Only: item control page